Lung cancer is the No. 1 cause of cancer deaths
in the United States, despite the fact it is largely preventable. For people at
high risk of developing lung cancer, such as current or former longtime
smokers, screening for the disease with low-dose CT scans is now a viable
option that has been shown to significantly reduce mortality rates. In
conjunction with National Lung Cancer Awareness Month, Seattle Cancer Care
Alliance (SCCA) wants to raise awareness about the importance of prevention and
early detection for at-risk populations.
A majority of patients diagnosed with lung cancer already have
incurable disease at the time of diagnosis. The large number of patients with
advanced lung cancer is the reason it is the leading cause of cancer-related
death in the United States -- more than breast, colon and prostate cancer
combined. However, by participating in screening that can detect cancer in its
earliest stages, lung cancer mortality can be lowered by as much as 20 percent,
according to results from the National Lung Screening Trial (NLST) that were
published in June 2011.
"Low-dose computed tomography screening for patients at high
risk of lung cancer saves lives," said David Madtes, M.D., director of
SCCA's Lung Cancer Early Detection and Prevention Clinic and director of the
low-dose CT screening program. "It is recommended by more than a dozen
medical societies and patient advocacy groups including the American Cancer
Society and the American Lung Association."
While lung cancer screening is not currently a routine part of
preventive medical care like mammography for breast cancer screening or the PSA
blood test to screen for prostate cancer, the results of the NLST trial are
changing clinical practice. Lung cancer experts now support lung cancer
screening to provide the opportunity to detect cancers at an earlier, treatable
and curable stage.
Douglas Wood, M.D., professor and chief of Cardiothoracic Surgery
at the University of Washington and a member of the multidisciplinary team that
treats lung cancer patients at SCCA, chairs the National Comprehensive Cancer
Network (NCCN) Lung Cancer Screening Panel which supports creating policies
that allow more patients access to screenings. Wood led the NCCN group that
published the initial set of guidelines in November 2011 and the guidelines
revision process this summer, which aims to make screening available with the
support of insurance and Medicare.
"Lung cancer screening for those at high risk is the biggest
game changer in lung cancer treatment in a generation," Wood said.
"The NLST study found that such screening could reduce mortality by 20
percent. We are on the cusp of changing guidelines and policies to help offer
screening that could impact millions of people."
Patients at high risk for lung cancer who benefited from CT
screening in the NLST met the following characteristics:
·
Ages 55-74
·
Current smokers or those
who quit within the last 15 years
·
Previous smokers with a
30 or more pack-year smoking history ("pack years" equals the average
number of packs of cigarettes smoked per day multiplied by the number of years
a person has smoked)
In addition to the above characteristics, the NCCN considers
individuals to be at high risk for lung cancer if they have the characteristics
listed below.
·
Age 50 or older
·
Smoked for 20 or more
pack years
·
Documented high radon
exposure
·
Occupational exposure to
silica, cadmium, asbestos, arsenic, beryllium, chromium, nickel or diesel fumes
·
A survivor of lung
cancer, lymphoma or head and neck cancer
·
A history of chronic
obstructive pulmonary disease or pulmonary fibrosis
·
A family history of lung
cancer
Currently, low-dose CT screening is not covered by most insurance
carriers, yet the out-of-pocket cost is relatively low at $300. Most follow-up
care required after the exam will be covered by insurance or Medicare/Medicaid.
0 comments:
Post a Comment